ROQ — Roquefort Therapeutics Share News
0.000.00%
Last trade - 00:00- £1.96m
- £2.17m
REG - Stock Exch Notice - Admission to Trading - 16/12/2025
AnnouncementREG - Roquefort Theraptcs. - Clinical Trial & License Agreement Update
AnnouncementREG - Roquefort Theraptcs. - Conversion of CLNs
AnnouncementREG - Roquefort Theraptcs. - Ex-Entitlement Date - Unlisted RNV Shares
AnnouncementREG - Roquefort Theraptcs. - Determination of Record Date and Entitlement
AnnouncementREG - Roquefort Theraptcs. - Holding(s) in Company
AnnouncementREG - Roquefort Theraptcs. - Director/PDMR Shareholding
AnnouncementREG - Roquefort Theraptcs. - Executed License Agreement & Transaction Update
AnnouncementREG - Roquefort Theraptcs. - MK Cell Out-License & Lyramid SPA Update
AnnouncementREG - Roquefort Theraptcs. - Fundraise & Transaction Update
AnnouncementREG - Cardiogeni PLC - Annual Results to 31 March 2025
AnnouncementREG - Roquefort Theraptcs. - Interim Results to 30 June 2025
AnnouncementRCS - Roquefort Theraptcs. - Investor Presentation via Engage Investor
AnnouncementREG - Roquefort Theraptcs. - Proposed Acquisition of Clinical Stage Company
AnnouncementREG - Roquefort Theraptcs. - Lyramid SPA 2nd Extension & Carve Out
AnnouncementREG - Roquefort Theraptcs. - Director/PDMR Shareholding
AnnouncementREG - Roquefort Theraptcs. - Director/PDMR Shareholding
AnnouncementREG - Roquefort Theraptcs. - Lyramid SPA Extension
AnnouncementREG - Roquefort Theraptcs. - Results of AGM
Announcement